Taraborelli Donna, Thomas Joanne J, Kim Lucas, Fashina Tolulope, Hayek Brent, Mattia John G, Vandy Matthew, Sugar Elizabeth, Crozier Ian, Yeh Steven, Shantha Jessica G
Harvard T.H. Chan School of Public Health, Harvard University, Cambridge.
Department of Ophthalmology, Medical College of Georgia, Augusta.
Glob J Cataract Surg Res Ophthalmol. 2023 May-Aug;2(2):23-29. doi: 10.25259/GJCSRO_29_2022. Epub 2023 Sep 13.
The objectives of this study were to assess relationships between vision-related quality of life (QoL) and visual acuity (VA) in Ebola virus disease (EVD) survivors after cataract surgery in the Ebola Viral Persistence in Ocular Tissues and Fluids (EVICT) Study.
EVD survivors with undetectable Ebola virus (EBOV) ribonucleic acid in their aqueous humour were eligible to receive manual small-incision cataract surgery (MSICS). Among those that received surgery, assessments of VA and vision-related QoL were assessed pre-and post-cataract surgery. VA was converted from units on a tumbling 'E' chart to the logarithm of the minimal angle of resolution VA (logMAR VA). Vision-related QoL was assessed using the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25). Linear regression was used to evaluate the associations between VA and vision-related QoL. = 0.05 was considered statistically significant for all analyses.
Thirty-four EVD survivors underwent cataract surgery in the EVICT study. Before MSICS, the mean logMAR VA was 2.24 (standard deviation [SD]: 0.98), and the mean NEI-VFQ-25 composite score was 54 (SD: 15); however, there was no significant association between the pre-surgery measurements (average difference in VA/10 unit increase in NEI-VFQ-25: -0.04, 95% confidence interval (CI): -0.33-0.26, = 0.80). There was a significant improvement in logMAR VA after MSICS (mean: 1.6, < 0.001), but there was no significant change in the NEI-VFQ-25 composite (-0.87, 95% (CI): -10.32-8.59, = 0.85). None of the subscales showed significant improvements ( > 0.12 for all); however, the magnitude of the mean change for distance activities (6.65), near activities (6.76), general vision (-7.69), social functioning (-9.13) and colour vision (13.33) met the criteria for a clinically meaningful difference (4-6). In the subset with paired measurements ( = 16), there were no significant association changes in logMAR VA and NEI VFQ-25 composite scores ( > 0.12 for all).
Following cataract surgery, VA in EVD survivors improved, but these improvements were not reflected in NEI VFQ-25 composite scores or specific subscales; however, the small sample size limits generalizability absent more research. Differences in sociocultural context and activities that affect the QoL in resource-limited areas may contribute to the limitations seen with NEI VFQ-25. In addition, better eye dominance could contribute to any lack of association as NEI VFQ-25 evaluates vision as a whole. Further, assessment of factors contributing to improved QoL may help to define the impact of vision health in varied environments.
在“眼部组织和体液中的埃博拉病毒持续存在”(EVICT)研究中,本研究的目的是评估埃博拉病毒病(EVD)幸存者白内障手术后视力相关生活质量(QoL)与视力(VA)之间的关系。
房水中检测不到埃博拉病毒(EBOV)核糖核酸的EVD幸存者有资格接受手法小切口白内障手术(MSICS)。在接受手术的患者中,在白内障手术前后对VA和视力相关QoL进行评估。VA从翻转“E”视力表上的单位转换为最小分辨角视力的对数(logMAR VA)。使用25项美国国立眼科研究所视觉功能问卷(NEI VFQ-25)评估视力相关QoL。采用线性回归评估VA与视力相关QoL之间的关联。所有分析中,P = 0.05被认为具有统计学意义。
34名EVD幸存者在EVICT研究中接受了白内障手术。在MSICS之前,平均logMAR VA为2.24(标准差[SD]:0.98),平均NEI-VFQ-25综合评分为54(SD:15);然而,术前测量之间无显著关联(NEI-VFQ-25每增加10个单位,VA的平均差异为:-0.04,95%置信区间[CI]:-0.33 - 0.26,P = 0.80)。MSICS后logMAR VA有显著改善(平均值:1.6,P < 0.001),但NEI-VFQ-25综合评分无显著变化(-0.87,95%[CI]:-10.32 - 8.59,P = 0.85)。所有子量表均未显示出显著改善(所有P > 0.12);然而,远距离活动(6.65)、近距离活动(6.76)、总体视力(-7.69)、社会功能(-9.13)和色觉(13.33)的平均变化幅度符合临床意义差异的标准(4 - 6)。在有配对测量的亚组(n = 16)中,logMAR VA和NEI VFQ-25综合评分无显著关联变化(所有P > 0.12)。
白内障手术后,EVD幸存者的VA有所改善,但这些改善未反映在NEI VFQ-25综合评分或特定子量表中;然而,样本量较小限制了在缺乏更多研究情况下的普遍性。社会文化背景和影响资源有限地区QoL的活动差异可能导致NEI VFQ-25出现局限性。此外,由于NEI VFQ-25将视力作为一个整体进行评估,更好的眼优势可能导致缺乏关联。此外,评估导致QoL改善的因素可能有助于确定视力健康在不同环境中的影响。